产后出血患者休克指数与舒张压的相关性及产后出血风险预警:4年大宗病例分析
该研究纳入2014年1月至2017年12月杭州师范大学附属医院产科病房402例产后出血患者(阴道分娩出血≥500 mL或剖宫产出血≥1000 mL)为观察组,同期416例分娩无并发症者为对照组,比较分娩前后临床指标。结果显示观察组产后24小时舒张压显著低于对照组(71.19±12.55 mmHg vs 75.68±8.96 mmHg),ΔDBP显著高于对照组(5.39±3.93 mmHg vs 0.67±0.33 mmHg),休克指数和心率显著升高,血红蛋白、红细胞计数、血小板计数和收缩压显著降低。Pearson相关分析显示产后舒张压与休克指数、24小时出血量、ΔDBP、血尿素氮和血肌酐呈负相关。序数回归分析显示ΔDBP≥9.32 mmHg时产后出血风险显著增加(RR=2.64,95%CI 1.94-3.34),且ΔDBP≥9.32 mmHg预警效果最佳。作者认为结合临床表现,休克指数和舒张压可作为产后出血病情观察的重要参考指标,ΔDBP≥9.32 mmHg可作为产后出血风险因素。
要点
- 产后出血患者产后24小时舒张压71.19±12.55 mmHg,低于对照组的75.68±8.96 mmHg(P<0.05)。
- 产后出血患者ΔDBP为5.39±3.93 mmHg,高于对照组的0.67±0.33 mmHg(P<0.01)。
- 序数回归显示ΔDBP≥9.32 mmHg时产后出血风险增加,RR=2.64(95%CI 1.94-3.34,P=0.000),预警效果最佳。
- 产后舒张压与休克指数(r=-0.419)、24小时出血量(r=-0.268)、ΔDBP(r=-0.490)均呈负相关(均P<0.05)。
- 作者认为结合临床表现,休克指数和舒张压可作为产后出血病情观察的重要参考指标。
适用人群与场景
- 2014年1月至2017年12月杭州师范大学附属医院产科病房收治的产后出血患者402例(产后24小时内阴道分娩出血≥500 mL或剖宫产出血≥1000 mL)为观察组。
- 同期同院分娩无并发症者416例为对照组。
诊断标准与关键阈值
- 产后出血定义:产后24小时内阴道分娩出血量≥500 mL,剖宫产出血量≥1000 mL。
- 序数回归分析提示ΔDBP≥9.32 mmHg时产后出血风险显著增加(RR=2.64,95%CI 1.94-3.34,P=0.000),且预警效果最佳。
- 序数回归分析提示SI≥0.95时产后出血风险增加(RR=1.78,95%CI 1.01-2.55,P=0.000)。
- 序数回归分析提示DBP≤59.64 mmHg时RR=0.86(95%CI 0.31-1.41,P=0.000)。
- 序数回归分析提示SBP≤105.86 mmHg时RR=0.63(95%CI 0.18-1.07,P=0.000)。
- 序数回归分析提示Hb≤77.89 g/L时RR=1.68(95%CI 0.99-2.38,P=0.000)。
研究设计与关键结果
- 研究类型为病例对照研究,观察组402例,对照组416例。
- 观察组年龄29.29±5.01岁高于对照组28.05±4.46岁,孕次2.68±1.42次多于对照组2.33±1.28次,孕周38.33±3.57周短于对照组39.05±1.40周,24小时出血量726.57±467.66 mL多于对照组244.49±50.25 mL(均P<0.01)。
- 观察组产后24小时DBP为71.19±12.55 mmHg,低于对照组75.68±8.96 mmHg(P<0.05);ΔDBP为5.39±3.93 mmHg,高于对照组0.67±0.33 mmHg(P<0.01)。
- 观察组SI为0.80±0.15高于对照组0.72±0.11,HR为91.56±13.37 bpm高于对照组82.96±11.76 bpm(均P<0.05)。
- 观察组Hb为91.30±13.41 g/L低于对照组112.30±13.41 g/L,RBC为3.74±0.38×10^12/L低于对照组4.59±0.45×10^12/L,PLT为173.02±59.08×10^9/L低于对照组182.09±54.76×10^9/L,SBP为115.13±9.27 mmHg低于对照组117.94±11.66 mmHg(均P<0.05)。
- Pearson相关分析显示产后DBP与SI(r=-0.419)、24小时出血量(r=-0.268)、ΔDBP(r=-0.490)、BUN(r=-0.108)、SCr(r=-0.163)呈负相关(均P<0.05),与SBP(r=0.739)、Hb(r=0.125)、RBC(r=0.096)呈正相关(均P<0.05)。
- 产后出血患者均止血成功,两组均未发现孕产妇及围产儿死亡。
证据类型、等级与局限
- 证据类型:病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为结合产后出血患者的临床表现,休克指数和舒张压可作为产后出血病情观察的重要参考指标。
- 作者认为ΔDBP≥9.32 mmHg可作为产后出血的风险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To observe the changes of shock index (SI) and diastolic blood pressure (DBP) in postpartum hemorrhage patients, and the explore their relationship with postpartum hemorrhage and the clinical significance of early warning of hemorrhage risk.
METHODS: 402 patients with postpartum hemorrhage (within 24 hours after delivery, the amount of bleeding in vaginal delivery ≥ 500 mL, and the amount of bleeding in caesarean delivery ≥ 1 000 mL) admitted to the obstetrics ward of Affiliated Hospital of Hangzhou Normal University from January 2014 to December 2017 were selected as the objective group and 416 without complications during delivery were selected as the control group in the same hospital at the same period. Clinical data in the two groups before and after childbirth was collected, including age, pregnancy week, 24-hour blood loss, and hemoglobin (Hb), whole blood cell parameters, heart rate (HR), systolic blood pressure (SBP), DBP, SI, blood urea nitrogen (BUN), serum creatinine (SCr) within 24 hours before and after delivery, and postpartum 24 hours and prenatal DBP difference (ΔDBP). The differences of indicators were compared between the two groups. Pearson method was used to analyze the correlation between the postpartum DBP and SI in the objective group. Ordinal regression model was used to analyze the early warning risk factors of each index to postpartum hemorrhage.
RESULTS: Compared with the control group, older age (years: 29.29±5.01 vs. 28.05±4.46), more pregnancies (times: 2.68±1.42 vs. 2.33±1.28), shorter gestation weeks (weeks: 38.33±3.57 vs. 39.05±1.40), more 24-hour blood loss (mL: 726.57±467.66 vs. 244.49±50.25) in the objective group were significant differences (all P < 0.01). Postpartum hemorrhage patients were successfully hemostatic, no maternal and perinatal death was found in the two groups. Compared with the control group, DBP was significantly decreased at 24 hours after delivery in the objective group [mmHg (1 mmHg = 0.133 kPa): 71.19±12.55 vs. 75.68±8.96, P < 0.05], and ΔDBP was significantly increased (mmHg: 5.39±3.93 vs. 0.67±0.33, P < 0.01). In addition, compared with the control group, SI and HR were significantly increased in the objective group [SI: 0.80±0.15 vs. 0.72±0.11, HR (bpm): 91.56±13.37 vs. 82.96±11.76, both P < 0.05], Hb, red blood cell count (RBC), platelet count (PLT) and SBP were significantly decreased [Hb (g/L): 91.30±13.41 vs. 112.30±13.41, RBC (×1012/L): 3.74±0.38 vs. 4.59±0.45, PLT (×109/L): 173.02±59.08 vs. 182.09±54.76, SBP (mmHg): 115.13±9.27 vs. 117.94±11.66, all P<0.05]. Correlation analysis showed that postpartum DBP was negatively correlated with SI, 24-hour blood loss, ΔDBP, BUN and SCr (r value was -0.419, -0.268, -0.490, -0.108, -0.163, respectively, all P < 0.05), and positively correlated with SBP, Hb and RBC (r value was 0.739, 0.125, 0.096, respectively, all P < 0.05). It was shown by Ordinal regression analysis that the risk of postpartum hemorrhage was significantly increased when ΔDBP ≥ 9.32 mmHg [relative risk (RR) = 2.64, 95% confidence interval (95%CI) = 1.94-3.34, P = 0.000], SI ≥ 0.95 (RR = 1.78, 95%CI = 1.01-2.55, P = 0.000), DBP ≤ 59.64 mmHg (RR = 0.86, 95%CI = 0.31-1.41, P = 0.000), SBP ≤ 105.86 mmHg (RR = 0.63, 95%CI = 0.18-1.07, P = 0.000), Hb ≤ 77.89 g/L (RR = 1.68, 95%CI = 0.99-2.38, P = 0.000), and ΔDBP ≥ 9.32 mmHg was the most effective early warning effect.
CONCLUSIONS: Combined with clinical manifestations of patients with postpartum hemorrhage, SI and DBP can be used as an important reference indicator for the observation of postpartum hemorrhage conditions. ΔDBP ≥ 9.32 mmHg can be used as the risk factors of the patient with postpartum hemorrhage.
参考来源
- Zu D, Zhuge Y. [Correlation between shock index and diastolic blood pressure in patients with postpartum hemorrhage and early warning of postpartum hemorrhage risk: an analysis of numerous cases in 4 years]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30439317. doi:10.3760/cma.j.issn.2095-4352.2018.010.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。